Adam R Aluisio1, Rose Bosire, Betz Bourke, Ann Gatuguta, James N Kiarie, Ruth Nduati, Grace John-Stewart, Carey Farquhar. 1. *Department of Emergency Medicine, Warren Alpert School of Medicine, Brown University, Providence, RI; †Centre for Public Health Research, Kenya Medical Research Institute, Nairobi, Kenya; ‡Department of Epidemiology, University of Washington, Seattle, WA; §School of Public Health, Kenyatta University, Nairobi, Kenya; ‖Department of Obstetrics & Gynecology, Kenyatta National Hospital, Nairobi, Kenya; ¶Department of Obstetrics & Gynecology, University of Nairobi, Nairobi, Kenya; **Department of Global Health, University of Washington, Seattle, WA; ††Department of Pediatrics and Child Health, University of Nairobi, Nairobi, Kenya; and ‡‡Department of Medicine, University of Washington, Seattle, WA.
Abstract
OBJECTIVE: This prospective study investigated the relationship between male antenatal clinic (ANC) involvement and infant HIV-free survival. METHODS: From 2009 to 2013, HIV-infected pregnant women were enrolled from 6 ANCs in Nairobi, Kenya and followed with their infants until 6 weeks postpartum. Male partners were encouraged to attend antenatally through invitation letters. Men who failed to attend had questionnaires sent for self-completion postnatally. Multivariate regression was used to identify correlates of male attendance. The role of male involvement in infant outcomes of HIV infection, mortality, and HIV-free survival was examined. RESULTS: Among 830 enrolled women, 519 (62.5%) consented to male participation and 136 (26.2%) men attended the ANC. For the 383 (73.8%) women whose partners failed to attend, 63 (16.4%) were surveyed through outreach. In multivariate analysis, male report of previous HIV testing was associated with maternal ANC attendance (adjusted odds ratio = 3.7; 95% CI: 1.5 to 8.9, P = 0.003). Thirty-five (6.6%) of 501 infants acquired HIV or died by 6 weeks of life. HIV-free survival was significantly greater among infants born to women with partner attendance (97.7%) than those without (91.3%) (P = 0.01). Infants lacking male ANC engagement had an approximately 4-fold higher risk of death or infection compared with those born to women with partner attendance (HR = 3.95, 95% CI: 1.21 to 12.89, P = 0.023). Adjusting for antiretroviral use, the risk of death or infection remained significantly greater for infants born to mothers without male participation (adjusted hazards ratio = 3.79, 95% CI: 1.15 to 12.42, P = 0.028). CONCLUSIONS: Male ANC attendance was associated with improved infant HIV-free survival. Promotion of male HIV testing and engagement in ANC/prevention of mother-to-child transmission services may improve infant outcomes.
OBJECTIVE: This prospective study investigated the relationship between male antenatal clinic (ANC) involvement and infantHIV-free survival. METHODS: From 2009 to 2013, HIV-infected pregnant women were enrolled from 6 ANCs in Nairobi, Kenya and followed with their infants until 6 weeks postpartum. Male partners were encouraged to attend antenatally through invitation letters. Men who failed to attend had questionnaires sent for self-completion postnatally. Multivariate regression was used to identify correlates of male attendance. The role of male involvement in infant outcomes of HIV infection, mortality, and HIV-free survival was examined. RESULTS: Among 830 enrolled women, 519 (62.5%) consented to male participation and 136 (26.2%) men attended the ANC. For the 383 (73.8%) women whose partners failed to attend, 63 (16.4%) were surveyed through outreach. In multivariate analysis, male report of previous HIV testing was associated with maternal ANC attendance (adjusted odds ratio = 3.7; 95% CI: 1.5 to 8.9, P = 0.003). Thirty-five (6.6%) of 501 infants acquired HIV or died by 6 weeks of life. HIV-free survival was significantly greater among infants born to women with partner attendance (97.7%) than those without (91.3%) (P = 0.01). Infants lacking male ANC engagement had an approximately 4-fold higher risk of death or infection compared with those born to women with partner attendance (HR = 3.95, 95% CI: 1.21 to 12.89, P = 0.023). Adjusting for antiretroviral use, the risk of death or infection remained significantly greater for infants born to mothers without male participation (adjusted hazards ratio = 3.79, 95% CI: 1.15 to 12.42, P = 0.028). CONCLUSIONS: Male ANC attendance was associated with improved infantHIV-free survival. Promotion of male HIV testing and engagement in ANC/prevention of mother-to-child transmission services may improve infant outcomes.
Authors: E W Kimani-Murage; J C Fotso; T Egondi; B Abuya; P Elungata; A K Ziraba; C W Kabiru; N Madise Journal: Health Place Date: 2014-07-11 Impact factor: 4.078
Authors: Frederick Morfaw; Lawrence Mbuagbaw; Lehana Thabane; Clarissa Rodrigues; Ana-Paula Wunderlich; Philip Nana; John Kunda Journal: Syst Rev Date: 2013-01-16
Authors: Jennifer Mark; John Kinuthia; Alison C Roxby; Daisy Krakowiak; Alfred Osoti; Barbra A Richardson; Molly Ann Gone; Victor Asila; Saloni Parikh; Carey Farquhar Journal: Sex Transm Dis Date: 2017-09 Impact factor: 2.830
Authors: Lora L Sabin; Nafisa Halim; Davidson H Hamer; Elizabeth M Simmons; Sivani Jonnalagadda; Anna Larson Williams; Harriet Chemusto; Allen L Gifford; Rachael Bonawitz; Philip Aroda; Mary DeSilva; Julia Gasuza; Barbara Mukasa; Lisa J Messersmith Journal: AIDS Behav Date: 2020-11
Authors: Natabhona M Mabachi; Melinda Brown; Matthew Sandbulte; Catherine Wexler; Kathy Goggin; May Maloba; Sarah Finocchario-Kessler Journal: AIDS Behav Date: 2020-01
Authors: Fatimah Oluwakemi Bello; Pamela Musoke; Zachary Kwena; George O Owino; Elizabeth A Bukusi; Lynae Darbes; Janet M Turan Journal: Women Health Date: 2019-02-07
Authors: Jillian Pintye; Kristin M Beima-Sofie; Pamela A Makabong'O; Anne Njoroge; Susan Brown Trinidad; Renee A Heffron; Jared M Baeten; Connie Celum; Daniel Matemo; John Kinuthia; Maureen C Kelley; Grace C John-Stewart Journal: AIDS Patient Care STDS Date: 2018-07-23 Impact factor: 5.078
Authors: Catherine A Koss; Paul Natureeba; Dalsone Kwarisiima; Mike Ogena; Tamara D Clark; Peter Olwoch; Deborah Cohan; Jaffer Okiring; Edwin D Charlebois; Moses R Kamya; Diane V Havlir Journal: J Acquir Immune Defic Syndr Date: 2017-03-01 Impact factor: 3.731
Authors: Violeta J Rodriguez; Gladys Matseke; Ryan Cook; Seanna Bellinger; Stephen M Weiss; Maria L Alcaide; Karl Peltzer; Doyle Patton; Maria Lopez; Deborah L Jones Journal: AIDS Behav Date: 2018-06